Guangzhou Baiyunshan Pharmaceutical Valuation
| GZPHFDelisted Stock | USD 2.88 0.00 0.00% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Guangzhou Baiyunshan retains a regular Real Value of $2.43 per share. The prevalent price of the firm is $2.88. Our model calculates the value of Guangzhou Baiyunshan from evaluating the firm fundamentals such as return on asset of 0.0356, and Return On Equity of 0.13 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Guangzhou Baiyunshan's price fluctuation is very steady at this time. Calculation of the real value of Guangzhou Baiyunshan is based on 3 months time horizon. Increasing Guangzhou Baiyunshan's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Guangzhou pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Guangzhou Baiyunshan Pharmaceutical. Since Guangzhou Baiyunshan is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Guangzhou Pink Sheet. However, Guangzhou Baiyunshan's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.88 | Real 2.43 | Hype 2.88 |
The real value of Guangzhou Pink Sheet, also known as its intrinsic value, is the underlying worth of Guangzhou Baiyunshan Company, which is reflected in its stock price. It is based on Guangzhou Baiyunshan's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Guangzhou Baiyunshan's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Guangzhou Baiyunshan Pharmaceutical helps investors to forecast how Guangzhou pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Guangzhou Baiyunshan more accurately as focusing exclusively on Guangzhou Baiyunshan's fundamentals will not take into account other important factors: Guangzhou Baiyunshan Total Value Analysis
Guangzhou Baiyunshan Pharmaceutical is currently forecasted to have takeover price of 5.65 B with market capitalization of 6.95 B, debt of 752.81 M, and cash on hands of 21.72 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Guangzhou Baiyunshan fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.65 B | 6.95 B | 752.81 M | 21.72 B |
Guangzhou Baiyunshan Investor Information
About 34.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.78. Some equities with similar Price to Book (P/B) outperform the market in the long run. Guangzhou Baiyunshan last dividend was issued on the 10th of June 2022. The entity had 10031:1000 split on the 28th of January 2014. Based on the analysis of Guangzhou Baiyunshan's profitability, liquidity, and operating efficiency, Guangzhou Baiyunshan Pharmaceutical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Guangzhou Baiyunshan Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Guangzhou Baiyunshan has an asset utilization ratio of 104.38 percent. This implies that the Company is making $1.04 for each dollar of assets. An increasing asset utilization means that Guangzhou Baiyunshan Pharmaceutical is more efficient with each dollar of assets it utilizes for everyday operations.Guangzhou Baiyunshan Ownership Allocation
Guangzhou Baiyunshan Pharmaceutical has a total of 219.9 Million outstanding shares. 30% of Guangzhou Baiyunshan outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Guangzhou Baiyunshan Profitability Analysis
The company reported the revenue of 69.01 B. Net Income was 3.72 B with profit before overhead, payroll, taxes, and interest of 13.19 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Guangzhou Baiyunshan's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Guangzhou Baiyunshan and how it compares across the competition.
About Guangzhou Baiyunshan Valuation
The pink sheet valuation mechanism determines Guangzhou Baiyunshan's current worth on a weekly basis. Our valuation model uses a comparative analysis of Guangzhou Baiyunshan. We calculate exposure to Guangzhou Baiyunshan's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Guangzhou Baiyunshan's related companies.Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the Peoples Republic of China and internationally. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China. Guangzhou Baiyunshan operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 25437 people.
8 Steps to conduct Guangzhou Baiyunshan's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Guangzhou Baiyunshan's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Guangzhou Baiyunshan's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Guangzhou Baiyunshan's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Guangzhou Baiyunshan's revenue streams: Identify Guangzhou Baiyunshan's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Guangzhou Baiyunshan's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Guangzhou Baiyunshan's growth potential: Evaluate Guangzhou Baiyunshan's management, business model, and growth potential.
- Determine Guangzhou Baiyunshan's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Guangzhou Baiyunshan's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Guangzhou Baiyunshan Growth Indicators
Investing in growth stocks can be very risky. If the company such as Guangzhou Baiyunshan does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.6 B | |
| Quarterly Earnings Growth Y O Y | 0.093 | |
| Retained Earnings | 17.5 B |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Guangzhou Pink Sheet
If you are still planning to invest in Guangzhou Baiyunshan check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Guangzhou Baiyunshan's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |